One of the most popular treatment for a variety of mental disorders like bipolar disorder, schizophrenia, and depression, Abilify makes billions for Otsuka Pharmaceutical Company and Bristol-Myers Squibb. With sales over $6.4 billion annually, it is one of the top-selling drugs in the U.S. Abilify works by either decreasing or…
Recent studies linking compulsive gambling to Abilify have triggered lawsuits across the country. A FDA report showed that from 2005 to 2013, at least 54 compulsive behaviors were reported by patients, including 30 reports of compulsive gambling. Reports of compulsive gambling have since been on the rise – more than…
Abilify lawsuits are now being filed nationwide alleging economic losses from Abilify. Bristol-Myers Squibb and Otsuka Pharmaceutical Co., the makers of Abilify are under fire for the side effects of their blockbuster drug. The companies are exposed to a new product liability lawsuit, which claims that the compulsive or pathological…